RE: AIHL and Future Pharmacogenetics30 Sep 2021 20:08
LTH14 They want £2m to launch in the US and obtain FDA. FDA can take up to 12 months as standard practice. It couldn't be bothered to look at a world class PCR during a pandemic, why would they consider the AIHL? UK and EU is a big enough market for little Genedrive. Better to use profits from sales to grow rather than digging a bigger debt hole. America will drain this particular cohort into oblivion. If AIHL is a sucess it will be big enough here and the EU, if it's not then whats the point of blowing another £2m save for the board enjoying some business class trips to the states?
They have lied and mislead. They will need something more than PI money to buy their institutional mates shares as has been proven by the failed open offer. They will want to protect their inflated salaries now and the only way to do that is to deliver. When you state people don't understand how a medical company works your a likely largely correct, but what most here will know is that if your costs exceed your total revenue then its an absolute non-starter. AIHL has been in the making for 3 years, they are about to launch and not a single press release - explain that? SP has been in the tightest range for years while forward selling is attempted - explain that?
Corrupt as fk.